Thierry Langer

Francesco Ortuso, Thierry Langer, Stefano Alcaro: GBPM: GRID-based pharmacophore model: concept and application studies to protein-protein recognition. Bioinformatics 22(12): 1449-1455 (2006)

Monika Rella, Christopher A. Rushworth, Jodie L. Guy, Anthony J. Turner, Thierry Langer, Richard M. Jackson: Structure-Based Pharmacophore Design and Virtual Screening for Novel Angiotensin Converting Enzyme 2 Inhibitors. Journal of Chemical Information and Modeling 46(2): 708-716 (2006)

Daniela Schuster, Christian Laggner, Theodora M. Steindl, Anja Palusczak, Rolf W. Hartmann, Thierry Langer: Pharmacophore Modeling and in Silico Screening for New P450 19 (Aromatase) Inhibitors. Journal of Chemical Information and Modeling 46(3): 1301-1311 (2006)

Joan R. Cucarull-González, Christian Laggner, Thierry Langer: Influence of the Conditions in Pharmacophore Generation, Scoring, and 3D Database Search for Chemical Feature-Based Pharmacophore Models: One Application Study of ET_A- and ET_B-Selective Antagonists. Journal of Chemical Information and Modeling 46(3): 1439-1455 (2006)

Johannes Kirchmair, Gerhard Wolber, Christian Laggner, Thierry Langer: Comparative Performance Assessment of the Conformational Model Generators Omega and Catalyst: A Large-Scale Survey on the Retrieval of Protein-Bound Ligand Conformations. Journal of Chemical Information and Modeling 46(4): 1848-1861 (2006)

Eva M. Krovat, Karin H. Frühwirth, Thierry Langer: Pharmacophore Identification, in Silico Screening, and Virtual Library Design for Inhibitors of the Human Factor Xa. Journal of Chemical Information and Modeling 45(1): 146-159 (2005)

Gerhard Wolber, Thierry Langer: LigandScout: 3-D Pharmacophores Derived from Protein-Bound Ligands and Their Use as Virtual Screening Filters. Journal of Chemical Information and Modeling 45(1): 160-169 (2005)

Johannes Kirchmair, Christian Laggner, Gerhard Wolber, Thierry Langer: Comparative Analysis of Protein-Bound Ligand Conformations with Respect to Catalyst's Conformational Space Subsampling Algorithms. Journal of Chemical Information and Modeling 45(2): 422-430 (2005)

Daniela Schuster, Thierry Langer: The Identification of Ligand Features Essential for PXR Activation by Pharmacophore Modeling. Journal of Chemical Information and Modeling 45(2): 431-439 (2005)

Theodora M. Steindl, Christian Laggner, Thierry Langer: Human Rhinovirus 3C Protease: Generation of Pharmacophore Models for Peptidic and Nonpeptidic Inhibitors and Their Application in Virtual Screening. Journal of Chemical Information and Modeling 45(3): 716-724 (2005)

Judith M. Rollinger, Sabine Haupt, Hermann Stuppner, Thierry Langer: Combining Ethnopharmacology and Virtual Screening for Lead Structure Discovery: COX-Inhibitors as Application Example. Journal of Chemical Information and Modeling 44(2): 480-488 (2004)

Eva M. Krovat, Thierry Langer: Impact of Scoring Functions on Enrichment in Docking-Based Virtual Screening: An Application Study on Renin Inhibitors. Journal of Chemical Information and Modeling 44(3): 1123-1129 (2004)

Theodora M. Steindl, Thierry Langer: Influenza Virus Neuraminidase Inhibitors: Generation and Comparison of Structure-Based and Common Feature Pharmacophore Hypotheses and Their Application in Virtual Screening. Journal of Chemical Information and Modeling 44(5): 1849-1856 (2004)

Thierry Langer, Rémy D. Hoffmann: On the Use of Chemical Function-Based Alignments as Input for 3D-QSAR. Journal of Chemical Information and Computer Sciences 38(2): 325-330 (1998)

Thierry Langer, Camille G. Wermuth: Inhibitors of prolyl endopeptidase: Characterization of the pharmacophoric pattern using conformational analysis and 3D-QSAR. Journal of Computer-Aided Molecular Design 7(3): 253-262 (1993)